Area of research
Reproductive Medicine · Genetics
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Cancer-related molecular mechanisms research, Genetic Associations and Epidemiology, and BRCA gene mutations in cancer.
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Genome-wide significant risk associations for mucinous ovarian carcinoma
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Network-Based Integration of GWAS and Gene Expression Identifies a <i>HOX</i> -Centric Network Associated with Serous Ovarian Cancer Risk
Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study
Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer
Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome